NDC 0378-4050 – Nevirapine
Nevirapine 200 mg/1 · Tablet · Oral
Product NDC0378-4050
Product details
- Brand name
- Nevirapine
- Generic name
- Nevirapine
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202523
- Marketed since
- May 22, 2012
- Listing expires
- December 31, 2027
- Pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Nevirapine 200 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0378-4050-91 | 60 TABLET in 1 BOTTLE, PLASTIC (0378-4050-91) | May 22, 2012 |
Other Nevirapine products
- 65162-209 Nevirapine 200 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65862-027 Nevirapine 200 mg/1 · Tablet · Aurobindo Pharma Limited
- 31722-505 Nevirapine 200 mg/1 · Tablet · Camber Pharmaceuticals, Inc.
- 33342-004 Nevirapine 200 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 42571-131 Nevirapine 200 mg/1 · Tablet · Micro Labs Limited
- 65862-057 Nevirapine Hemihydrate 50 mg/5mL · Suspension · Aurobindo Pharma Limited
- 33342-238 Nevirapine 400 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 0378-4890 Nevirapine 400 mg/1 · Tablet, Extended Release · Mylan Pharmaceuticals Inc.